Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation
Stopped accrual of evaluable subjects too low
Conditions
- Stem Cell Transplantation
Interventions
- BIOLOGICAL: Thymic Transplantation for Recipients of UCB transplant
Sponsor
Sumitomo Pharma Switzerland GmbH